Mar-25-21 08:00AM | |
Mar-21-21 09:52PM | |
Mar-18-21 08:01PM | |
Mar-16-21 10:00PM | |
Mar-12-21 06:15AM | |
Mar-10-21 08:00AM | |
Mar-09-21 10:45PM | |
Mar-08-21 08:00AM | |
Mar-07-21 05:53PM | |
Mar-03-21 03:00AM | |
Feb-22-21 01:10PM | |
Feb-20-21 07:00PM | |
Feb-18-21 09:47PM | |
04:45PM | |
Feb-17-21 11:38AM | |
Feb-16-21 08:52AM | |
Feb-15-21 09:13PM | |
Feb-10-21 04:06PM | |
Feb-08-21 08:22AM | |
12:26AM | |
Feb-02-21 07:32PM | |
Jan-26-21 08:00AM | |
Jan-06-21 08:49AM | |
Dec-07-20 12:49AM | |
Dec-04-20 07:43AM | |
07:00AM | |
Dec-01-20 08:40AM | |
Nov-27-20 10:27AM | |
Nov-20-20 10:45AM | |
Nov-12-20 04:30PM | |
Nov-10-20 07:12AM | |
Nov-05-20 08:00AM | |
Oct-19-20 08:00AM | |
Sep-24-20 08:00AM | |
Sep-09-20 08:00AM | |
Aug-27-20 08:00AM | |
Aug-18-20 09:21AM | |
Aug-17-20 08:00AM | |
Aug-14-20 08:00AM | |
Aug-12-20 08:11AM | |
08:10AM | |
Aug-06-20 04:05PM | |
Jul-29-20 08:00AM | |
Jul-28-20 06:09PM | |
Jul-22-20 08:00AM | |
Jun-14-20 07:00AM | |
Jun-12-20 04:27PM | |
Jun-09-20 08:00AM | |
Jun-02-20 09:44AM | |
May-27-20 08:00AM | |
May-14-20 11:44AM | |
May-12-20 04:05PM | |
May-07-20 08:00AM | |
May-06-20 08:30AM | |
Apr-30-20 04:05PM | |
Apr-06-20 08:30AM | |
Apr-02-20 08:00AM | |
Mar-17-20 08:00AM | |
Mar-16-20 08:00AM | |
Feb-13-20 08:00AM | |
Feb-10-20 04:05PM | |
Feb-05-20 09:00PM | |
Jan-30-20 08:18AM | |
Jan-13-20 08:00AM | |
Jan-08-20 04:05PM | |
Jan-05-20 08:14AM | |
Jan-03-20 10:15AM | American City Business Journals -8.92% |
Dec-22-19 06:38PM | |
Dec-13-19 11:16AM | |
Dec-11-19 06:32PM | |
Dec-09-19 08:44AM | |
Dec-07-19 01:00PM | |
Dec-02-19 01:56PM | |
Nov-26-19 04:05PM | |
Nov-12-19 04:05PM | |
Nov-08-19 10:34AM | |
Nov-07-19 08:18AM | |
Nov-01-19 08:00AM | |
Oct-09-19 09:14AM | |
Oct-07-19 09:36AM | |
Sep-26-19 08:00AM | |
Sep-23-19 10:54AM | |
Aug-08-19 11:45AM | |
Jul-31-19 04:05PM | |
Jul-17-19 11:00AM | |
Jul-10-19 08:00AM | |
Jul-05-19 10:05AM | American City Business Journals -6.21% |
Jul-01-19 02:08PM | American City Business Journals +6.52% |
Jun-26-19 12:31PM | |
Jun-19-19 08:00AM | |
Jun-10-19 08:00AM | |
May-08-19 07:22PM | |
May-04-19 05:25PM | |
|
|
|
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lamond David | Director | Mar 24 | Buy | 33.77 | 50,000 | 1,688,500 | 1,847,109 | Mar 24 09:06 PM | Lynch Casey | Chief Executive Officer | Mar 22 | Sale | 35.59 | 30,000 | 1,067,611 | 1,008,774 | Mar 23 07:06 PM | Lamond David | Director | Mar 04 | Buy | 35.34 | 50,000 | 1,767,057 | 1,797,109 | Mar 05 05:54 PM | Lynch Casey | Chief Executive Officer | Feb 03 | Sale | 43.03 | 20,000 | 860,530 | 1,038,774 | Feb 03 07:45 PM | Lynch Casey | Chief Executive Officer | Feb 02 | Sale | 36.21 | 20,000 | 724,102 | 1,058,774 | Feb 03 07:45 PM | Lynch Casey | Chief Executive Officer | Feb 01 | Sale | 36.25 | 20,000 | 724,968 | 1,078,774 | Feb 03 07:45 PM | Holsinger Leslie | Executive Vice President | Dec 14 | Option Exercise | 0.27 | 40,000 | 10,800 | 43,500 | Dec 15 07:17 PM | Holsinger Leslie | Executive Vice President | Dec 14 | Sale | 30.81 | 40,000 | 1,232,528 | 1,800 | Dec 15 07:17 PM | Holsinger Leslie | Executive Vice President | Dec 10 | Option Exercise | 0.27 | 3,500 | 945 | 3,500 | Dec 14 05:16 PM | EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | Jun 12 | Buy | 44.06 | 2,440 | 107,506 | 2,860,967 | Jun 15 06:55 PM | EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | Jun 11 | Buy | 44.32 | 6,600 | 292,512 | 2,858,527 | Jun 15 06:55 PM | Lamond David | Director | Jun 04 | Buy | 43.27 | 49,125 | 2,125,795 | 1,747,109 | Jun 08 06:47 PM | PFIZER INC | 10% Owner | Jun 03 | Sale | 40.18 | 370,000 | 14,866,600 | 2,879,973 | Jun 04 04:25 PM | Detke Michael J. | Chief Medical Officer | May 27 | Option Exercise | 6.91 | 5,515 | 38,109 | 28,261 | May 29 04:48 PM | EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 22 | Buy | 55.90 | 2,085 | 116,552 | 2,851,927 | May 22 06:03 PM | EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 21 | Buy | 55.80 | 520 | 29,016 | 2,849,842 | May 22 06:03 PM | EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 20 | Buy | 57.95 | 6,085 | 352,605 | 2,849,322 | May 22 06:03 PM | Lamond David | Director | May 19 | Buy | 56.24 | 39,200 | 2,204,683 | 1,697,984 | May 19 06:41 PM | Lamond David | Director | May 15 | Buy | 48.93 | 5,448 | 266,569 | 1,658,784 | May 19 06:41 PM |
|